CAAS Capital Management’s Biodesix BDSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,000
Closed -$403K 1154
2020
Q4
$403K Buy
+1,000
New +$311K ﹤0.01% 709

Other funds holding BDSX

CAAS Capital Management's BDSX Position: Q1 2021 in Review

CAAS Capital Management sold out of Biodesix (BDSX) in Q1 2021, closing a stake of 1,000 shares — an estimated $403K sold.

CAAS Capital Management first reported a position in BDSX in Q4 2020 and held it in 1 quarter. The position peaked at $403K in Q4 2020. 46 funds tracked by Wall St. Rank hold BDSX as of Q1 2021.

  • CAAS Capital Management reported no remaining Biodesix position as of Q1 2021 after selling out during the quarter.
  • CAAS Capital Management sold 1,000 Biodesix shares in Q1 2021, an estimated $403K.
  • CAAS Capital Management first reported a position in Biodesix in Q4 2020 and held it in 1 quarter.
  • CAAS Capital Management's Biodesix position peaked at $403K in Q4 2020.
  • 46 funds tracked by Wall St. Rank held Biodesix as of Q1 2021.

Based on CAAS Capital Management's 13F filing for Q1 2021, filed 17 May 2021.